class="wp-theme-Newspaper supp-body td-standard-pack global-block-template-1 tdc-header-template tdc-footer-template td-animation-stack-type0 td-full-layout"
EU mandatory warning: "May have an adverse effect on activity and attention in children." FDA requires specific label declaration. Cross-reacts with aspirin in 10-40% of aspirin-sensitive individuals causing urticaria/asthma. Avoid in asthma, urticaria, aspirin sensitivity, ADHD. Norway banned tartrazine (later lifted with EU harmonisation). Significant hyperactivity concern in children.
Synthetic azo dye (tartrazine) — yellow food colouring. Most studied of FD&C dyes due to well-documented hypersensitivity reactions. Associated with urticaria, asthma exacerbation, and hyperactivity in children. Cross-reacts with aspirin in salicylate-sensitive individuals. EU mandatory disclosure required.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly unsafe | — |
| Pregnancy | Possibly unsafe | — |
| Elderly | Possibly unsafe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)